6515--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0166 762-25-2-040-1128 -Tucson CMOP TRAZODONE
ID: 36C77025Q0166Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)

Original Source

https://sam.gov/opp/2a7deae86541445a9e1f02a226649b97/view
Timeline
    Description

    The Department of Veterans Affairs is seeking proposals for the procurement of Trazodone HCL 50MG tablets through Solicitation Number 36C77025Q0166, specifically for the VA Consolidated Mail Outpatient Pharmacy (CMOP) in Tucson, Arizona. This contract is set aside for small businesses and requires compliance with the Buy American Act, necessitating separate quotes for foreign and domestic products. Trazodone is a critical medication used in the treatment of depression and anxiety, making this procurement essential for the healthcare services provided to veterans. Interested vendors must submit their quotations, including a signed SF1449 cover page and proof of state wholesale distributor licensure, by March 3, 2025, to the Contract Specialist, Michael W. McAlhaney, at Michael.McAlhaney@va.gov.

    Point(s) of Contact
    Michael W McAlhaneyContracting Specialist
    Michael.McAlhaney@va.gov
    Files
    Title
    Posted
    36C77025Q0166_1.docx
    The document outlines a procurement solicitation from the Department of Veterans Affairs (VA) for pharmaceutical products, specifically for Trazodone HCL 50mg tablets. The solicitation, referenced as 36C77025Q0166, seeks quotes from vendors for 792,000 units at a unit price yet to be determined. Key components include delivery requirements, documentation needed from vendors, and compliance with the Drug Supply Chain Security Act (DSCSA). Vendors must submit a signed SF1449 form, completed price schedules in Excel format, and proof of a State Wholesale Distributor License. The procurement emphasizes the preference for U.S.-made products, and conditions for shipping are specified, including the requirement for all products to be shippable via USPS. It also highlights essential terms for contract compliance, including invoice submission, inspection rights, and dispute resolution procedures. Overall, this solicitation underscores the VA's commitment to sourcing pharmaceuticals while ensuring quality and compliance with federal regulations, targeting both small businesses and larger distributors in the pharmaceutical sector.
    36C77025Q0166.docx
    The Department of Veterans Affairs (VA) is seeking proposals for the procurement of Trazodone HCL 50MG tablets through Solicitation Number 36C77025Q0166. The contract location is the VA Consolidated Mail Outpatient Pharmacy (CMOP) in Tucson, AZ, with an estimated delivery timeframe of 10 days after receipt of order. The solicitation is set aside for small businesses and requires compliance with the Buy American Act, necessitating separate quotes for foreign and domestic products. Interested vendors must submit their quotations, including a signed SF1449 cover page, a detailed price schedule in Excel format, and proof of state wholesale distributor licensure under the Drug Supply Chain Security Act (DSCSA). Proposals are due by March 3, 2025, and must be sent to the Contract Specialist, Michael W. McAlhaney. It is essential for vendors to monitor the Contract Opportunities website for any updates related to the solicitation. The document outlines the requirements, responsibilities, and conditions for submitting a proposal to ensure compliance with federal regulations and standards.
    52.225-2 BUY AMERICAN CERTIFICATE.docx
    The document outlines the Buy American Certificate (October 2022) requirements for federal government procurement. It mandates that Offerors certify all end products, except those specified, as domestic and containing critical components. It distinguishes between domestic and foreign end products, stipulating that foreign items manufactured in the U.S. be listed if they do not qualify as domestic. Additionally, for foreign products, Offerors must indicate if they exceed 55% domestic content, barring commercially available off-the-shelf (COTS) items. The document requests a separate list of domestic end products with critical components and emphasizes the evaluation of offers according to the Federal Acquisition Regulation's policies. This requirement promotes the use of domestically sourced products in government contracts, aiming to support domestic manufacturing and ensure compliance with national procurement standards.
    S02_Solicitation_Attachment_Pricing SpreadSheet_RFQ_36C77025Q0166.xlsx
    The document outlines a Request for Quotation (RFQ) for Trazodone HCL 50mg tablets, specifically seeking quotes for the supply of 1,000-count bottles. The estimated issue date of the RFQ is February 24, 2025, with a submission deadline of March 3, 2025, at 9:00 AM (CST). Bids must comply with the Drug Supply Chain Security Act (DSCSA), requiring suppliers to provide state wholesale distributor licensure along with their quotes to establish compliance. Non-compliance will render offers technically unacceptable. Required submission documents include an SF1449 form, a price schedule, proof of licensure, and a completed Buy American Certificate. Additionally, vendors must ensure that all relevant documentation is submitted in the correct format, such as EDI, EPCIS, or ASN. The preferred delivery date for the products is March 20, 2025. The delivery address is the VA CMOP Tucson facility in Arizona. The RFQ reflects the government's effort to maintain secure and compliant drug supply chains while adhering to regulatory requirements.
    Similar Opportunities
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0167 762-25-2-040-1129 -Tucson CMOP SERTRALINE HCL
    Buyer not available
    The Department of Veterans Affairs is seeking quotations for the procurement of Sertraline HCL 100MG tablets (500 count) under solicitation RFQ: 36C77025Q0167. This procurement aims to ensure compliance with the Drug Supply Chain Security Act (DSCSA) and requires suppliers to provide documentation such as a signed SF1449 solicitation cover page, a pricing schedule, and a completed Buy American Certificate, emphasizing the importance of domestic sourcing. The expected delivery date for the pharmaceuticals is March 21, 2025, with a submission deadline for offers set for March 4, 2025. Interested parties should contact Contracting Specialist Michael W McAlhaney at Michael.McAlhaney@va.gov for further information.
    Trazodone HCL
    Buyer not available
    Solicitation DEPT OF DEFENSE is procuring Trazodone HCL, a drug used for treating depression and anxiety. The procurement will take place at DLA Troop Support in Philadelphia, PA (zip code: 19111), USA. For more information, contact Christopher Newman at christopher.newman@dla.mil or 215-737-2905.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0168 762-25-2-040-1176 -Tucson CMOP HYDROXYCHLOROQUINE SULFATE
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of Hydroxychloroquine Sulfate 200mg tablets, with a total quantity of 5,412 to be delivered to the CMOP facility in Tucson, Arizona. This presolicitation, identified by solicitation number 36C77025Q0168, is set aside for small businesses and requires compliance with the Buy American statute, necessitating quotes for both foreign and domestic products. Hydroxychloroquine is a critical pharmaceutical used in the treatment of various conditions, making this procurement essential for the healthcare services provided to veterans. Interested vendors must submit their proposals by March 5, 2025, at 09:00 Central Time, and can direct inquiries to Contract Specialist Michael W. McAlhaney via email at Michael.McAlhaney@va.gov or by phone at (913) 684-0134.
    Tucson CMOP DIVALPROEX
    Buyer not available
    The Department of Veterans Affairs is seeking qualified small businesses to supply Divalproex Sodium 125mg Sprinkle Capsules under Contract Number 36C77025Q0131 for the Tucson CMOP. This procurement requires vendors to comply with strict shipping regulations, provide National Drug Codes (NDC), and ensure product availability while adhering to the Drug Supply Chain Security Act documentation. The pharmaceuticals are essential for the healthcare of veterans, emphasizing the government's commitment to quality and reliability in pharmaceutical supplies. Interested vendors must submit their proposals, including a signed SF 1449 form and a valid wholesale distributor license, by 4:00 PM CST on March 6, 2025, with all submissions directed to Sarah Fry at sarah.fry2@va.gov.
    6509--Solifenacin Tabletes (VA-25-00037090)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, designated as RFP 36E79725R0020. This procurement aims to establish a reliable supply of Solifenacin for the VA, Department of Defense (DoD), and other federal health agencies, with the contract expected to last one year and include four optional renewal periods. Solifenacin is a critical medication used in the treatment of overactive bladder, highlighting the VA's commitment to ensuring access to essential pharmaceuticals for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the RFP release, anticipated around March 14, 2025, with proposals due by March 28, 2025; for further inquiries, they may contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--Mycophenolate Mofetil RFP
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of Mycophenolate Mofetil capsules and tablets under Solicitation Number 36E79725R0010, aimed at establishing national pricing for these pharmaceutical products. The contract is intended to support various government health care facilities, including those under the Department of Defense and Indian Health Service, ensuring compliance with FDA standards and the Drug Supply Chain Security Act. Offerors are required to submit pricing for both the base year and four option years, with a deadline for submissions extended to March 4, 2025, at 2:30 PM CST, and must acknowledge receipt of this amendment to avoid rejection of their offers. Interested parties can contact Contract Specialist Amber Zavala at amber.zavala@va.gov for further information.
    6505--770-25-1-801-0131 -National CMOP DORZOLAMIDE/TIMOLOL -(VA-25-00027395)
    Buyer not available
    The Department of Veterans Affairs is soliciting bids for the procurement of Dorzolamide 22.3/Timolol 6.8mg/ml ophthalmic solution as part of its National Consolidated Mail Outpatient Pharmacy (CMOP) program. This solicitation requires vendors to submit a signed cover page, pricing schedule, and documentation such as a valid state distributor license and a Trade Agreements Act certificate, ensuring compliance with regulatory standards for pharmaceutical products. The procurement is critical for providing quality healthcare services to veterans, emphasizing the importance of product safety, therapeutic equivalence, and adherence to delivery schedules. Interested vendors must submit their quotes by March 5, 2025, at 3:00 PM Central Time, and can contact Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov for further inquiries.
    Q517--Staffing Service Tucson
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for staffing services at the Tucson Consolidated Mail Outpatient Pharmacy (CMOP), specifically for pharmacists, pharmacy technicians, and shipper/packer roles. The contract, set aside for Service-Disabled Veteran-Owned Small Businesses (SDVOSB), aims to ensure the efficient processing of over 15 million prescriptions annually, with a minimum staffing requirement of 70 full-time equivalents (FTE) and a target of maintaining at least 97% staffing levels. This procurement is critical for delivering quality healthcare services to veterans, reflecting the government's commitment to supporting veteran-owned enterprises. Interested contractors must submit their proposals by the newly established deadline of July 23, 2024, and can direct inquiries to Contract Specialist Nicholas L. Schulte at nicholas.schulte1@va.gov or Christy Pendlay at Christy.Pendlay@va.gov.
    6505--Hydroxychloroquine SO4 Tablets
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a Request for Proposal (RFP) for the procurement of Hydroxychloroquine SO4 Tablets, aimed at ensuring a continuous supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will cover an estimated annual requirement of 163,395 bottles of 100-count and 25,853 bottles of 500-count Hydroxychloroquine tablets, with a contract period of one year and four optional one-year extensions. This procurement is critical for maintaining essential medications within veteran and federal healthcare programs. Interested parties should monitor SAM.gov for updates and direct inquiries to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov or (708) 786-4980, with submissions due by March 26, 2025.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.